Free Trial
NASDAQ:CELU

Celularity (CELU) Stock Price, News & Analysis

Celularity logo
$2.06 +0.02 (+0.74%)
As of 03:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Celularity Stock (NASDAQ:CELU)

Advanced

Key Stats

Today's Range
$2.00
$2.15
50-Day Range
$2.04
$4.15
52-Week Range
$1.00
$5.22
Volume
71,325 shs
Average Volume
169,504 shs
Market Capitalization
$54.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Celularity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

CELU MarketRank™: 

Celularity scored higher than 50% of companies evaluated by MarketBeat, and ranked 578th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Celularity has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    Celularity has a consensus price target of $6.00, representing about 192.0% upside from its current price of $2.06.

  • Amount of Analyst Coverage

    Celularity has only been the subject of 1 research reports in the past 90 days.

  • Read more about Celularity's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Celularity is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Celularity is -0.65, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Celularity has a P/B Ratio of 5.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Celularity's valuation and earnings.
  • Percentage of Shares Shorted

    9.39% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 17.16%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Celularity does not currently pay a dividend.

  • Dividend Growth

    Celularity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.39% of the float of Celularity has been sold short.
  • Short Interest Ratio / Days to Cover

    Celularity has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Celularity has recently decreased by 17.16%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Celularity has a news sentiment score of 1.20. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Celularity this week, compared to 1 article on an average week.
  • Search Interest

    9 people have searched for CELU on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Celularity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    22.10% of the stock of Celularity is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.02% of the stock of Celularity is held by institutions.

  • Read more about Celularity's insider trading history.
Receive CELU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Celularity and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CELU Stock News Headlines

WBB Securities Upgrades Celularity (CELU)
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.tc pixel
Celularity Receives Nasdaq Notice Regarding Form 10-Q
BRIEF-Celularity Completes Major Balance Sheet Restructuring
See More Headlines

CELU Stock Analysis - Frequently Asked Questions

Celularity's stock was trading at $2.08 on January 1st, 2025. Since then, CELU stock has decreased by 1.2% and is now trading at $2.0550.

Celularity, Inc. (NASDAQ:CELU) issued its quarterly earnings results on Friday, August, 29th. The company reported ($1.02) EPS for the quarter. The business had revenue of $5.74 million for the quarter. Celularity had a negative trailing twelve-month return on equity of 459.57% and a negative net margin of 165.22%.

Shares of Celularity reverse split before market open on Thursday, February 29th 2024.The 1-10 reverse split was announced on Thursday, February 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of CELU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Celularity investors own include NVIDIA (NVDA), Meta Platforms (META), Lovesac (LOVE), MannKind (MNKD), PayPal (PYPL), Tesla (TSLA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/29/2025
Today
10/02/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CELU
CIK
1752828
Fax
N/A
Employees
220
Year Founded
2016

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+194.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.18)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.89 million
Net Margins
-165.22%
Pretax Margin
-165.21%
Return on Equity
-459.57%
Return on Assets
-57.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.25
Quick Ratio
0.19

Sales & Book Value

Annual Sales
$54.22 million
Price / Sales
1.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.37 per share
Price / Book
5.51

Miscellaneous

Outstanding Shares
26,690,000
Free Float
20,792,000
Market Cap
$54.45 million
Optionable
Optionable
Beta
0.76

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CELU) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners